World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
12539
World Ranking
2537
National Ranking
220

Hans J. Stauss publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hans J. Stauss sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 315 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hans J. Stauss D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hans J. Stauss sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hans J. Stauss is affiliated with University College London in the United Kingdom and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research encompasses a range of subfields, including Immunology, Oncology, Infectious Diseases, Molecular Biology, and Genetics.

Stauss's work centers around several main topics: CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Virus-based gene therapy research.

Their recent published papers include the following:

  • The effect of spike mutations on SARS-CoV-2 neutralization, 2021, Cell Reports
  • Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells, 2020, Immunity
  • An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease, 2021, Nature Immunology
  • Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients, 2021, The Lancet
  • Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds, 2020, Nature Communications

Stauss frequently collaborates with other researchers, including Angelika Holler, Jesmeen Maimaris, Ronjon Chakraverty, Sharyn Thomas, and Maxine Tran, indicating a network of professional cooperation primarily centered around immunology and related biomedical fields.

The most common venues for Stauss's research publications are bioRxiv (Cold Spring Harbor Laboratory), Cells, Nature Communications, Blood, and Frontiers in Immunology. This reflects a broad spectrum of contributions to both preprint platforms and peer-reviewed journals focused on cellular biology and immunology.

Best Publications

  • Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity

    Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz

  • Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.

    Liquan Gao;Ilaria Bellantuono;Annika Elsässer;Stephen B. Marley

  • Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.

    Thomas Stanislawski;Ralf-Holger Voss;Carina Lotz;Elena Sadovnikova

  • Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice

    Julia Yuen-Shan Tsang;Yakup Tanriver;Shuiping Jiang;Shao-An Xue

  • Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.

    Graham P. Wright;Clare A. Notley;Shao-An Xue;Gavin M. Bendle

  • Isolation of endothelial cells from murine tissue.

    Federica M Marelli-Berg;Emma Peek;Elaine A Lidington;Hans J Stauss

  • Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.

    Shao-An Xue;Liquan Gao;Daniel Hart;Roopinder Gillmore

  • Whole-genome sequencing of a sporadic primary immunodeficiency cohort

    Thaventhiran Jed.;H Lango Allen;O S Burren;W Rae

  • Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

    Adam J. Gehring;Shao-An Xue;Zi Zong Ho;Denise Teoh

  • Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

    Paul Tuijnenburg;Hana Lango Allen;Hana Lango Allen;Siobhan O. Burns;Daniel Greene;Daniel Greene

  • The effect of spike mutations on SARS-CoV-2 neutralization.

    Chloe Rees-Spear;Luke Muir;Sarah A. Griffith;Judith Heaney

  • Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

    Waseem Qasim;Maurizia Brunetto;Adam J. Gehring;Shao-An Xue

  • Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

    Atfa Sassi;Sandra Lazaroski;Gang Wu;Stuart M. Haslam

  • Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells.

    Anna Śledzińska;Maria Vila de Mucha;Katharina Bergerhoff;Alastair Hotblack

  • Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.

    Jian-Guo Chai;Shao-an Xue;David Coe;Caroline Addey

  • Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: Reagents for tumor immunotherapy

    Elena Sadovnikova;Hans J. Stauss

  • Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

    Peng H. Tan;Sven C. Beutelspacher;Shao-An Xue;Yao-He Wang

  • Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules

    Elena Sadovnikova;Louise A. Jopling;Kenneth S. Soo;Hans J. Stauss

  • An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

    Yanchun Peng;Suet Ling Felce;Danning Dong;Danning Dong;Frank Penkava

  • Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds

    Ravit Oren;Moran Hod-Marco;Maya Haus-Cohen;Sharyn Thomas

  • Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette.

    Matthias Leisegang;Boris Engels;Peter Meyerhuber;Elisa Kieback

Frequent Co-Authors

Emma Morris
Emma Morris University College London
Antonio Bertoletti
Antonio Bertoletti Duke NUS Graduate Medical School
Hans Schreiber
Hans Schreiber University of Chicago
Adrian J. Thrasher
Adrian J. Thrasher University College London
Mala K. Maini
Mala K. Maini University College London
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Rose Zamoyska
Rose Zamoyska University of Edinburgh
Wolfgang Uckert
Wolfgang Uckert Max Delbrück Center for Molecular Medicine
Siobhan O. Burns
Siobhan O. Burns University College London
Benjamin M. Chain
Benjamin M. Chain University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens the door to various healthcare career opportunities, especially in advanced nursing roles. For those interested in advancing their clinical expertise, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) is a valuable step. Understanding how to make this shift effectively can expand your scope of practice and improve patient outcomes. Learn more about this transition by exploring fnp to acnp.

Many students find accelerated pathways to becoming nurse practitioners essential for fast-tracking their careers. Programs highlighted in accelerated nurse practitioner programs offer flexible formats and competitive curriculums designed to meet growing healthcare demands.

For aspiring nurses without a formal background, enrolling in recognized online Associate Degree in Nursing options is a practical starting point. The guide on online adn programs for non nurses provides essential information for newcomers entering the nursing field through remote education.

Salary prospects for advanced practice roles, especially with a Doctor of Nursing Practice (DNP) degree, vary across states. Examining the dnp salary landscape can help inform career decisions and geographic preferences.

Best Scientists Citing Hans J. Stauss

Trending Scientists

Recently Published Articles